India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Major Indian cities face severe air pollution crisis with Delhi's AQI hitting 'Very Poor' category. Mumbai and Bengaluru also report dangerously high pollution levels affecting millions of residents.
While Delhi's overall AQI shows signs of improvement, Anand Vihar continues to battle severe air pollution levels, raising health concerns for residents.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Delhi-NCR's air quality crisis deepens as AQI hits 'Severe' category in Noida, Ghaziabad, Faridabad, and Gurugram. CPCB and SAFAR data show dangerous pollution levels with health warnings issued.
As Delhi braces for Diwali celebrations, the city's air quality continues to deteriorate rapidly, with experts predicting AQI levels could hit 'very poor' category. Meteorological conditions and festival fireworks create a perfect storm for pollution.
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
In a bold move to ensure quality infrastructure, Punjab Chief Minister Bhagwant Mann has formed a special flying squad to monitor road construction projects across the state. This initiative aims to eliminate corruption and substandard work in road develo
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
As Delhi's AQI reaches hazardous levels, medical experts reveal the terrifying long-term damage pollution causes to your respiratory system and how to protect yourself.
Delhi's air quality deteriorates to 'Poor' levels with Anand Vihar and Akshardham among worst-hit areas. Real-time AQI data reveals concerning pollution spike across NCR.
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Mumbai Crime Branch arrests wanted drug smuggler Lalit Patil after massive nationwide manhunt in connection with record ₹252 crore pharmaceutical drug seizure case.
As Diwali approaches, discover how AI-powered smart air purifiers with real-time monitoring and voice control are revolutionizing indoor air quality management across Indian households.
Mumbai wakes up to hazardous air as AQI hits 181, while Pune records 'moderate' pollution at 132. BMC issues health advisory as Maharashtra's financial capital battles deteriorating air quality.
Delhi's air pollution crisis intensifies as AQI hits 'severe' category. Anand Vihar records alarming 999 AQI, triggering health warnings for residents. Real-time updates and expert insights.
Despite Diwali celebrations ending, Chandigarh continues to choke as air quality remains in the 'Poor' category with AQI at 256. Authorities warn residents as pollution levels show no signs of improvement.
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
Shocking revelation by AAP's Saurabh Bhardwaj alleges four government bodies manipulated Delhi's air quality data during Diwali, raising serious questions about transparency in pollution monitoring.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Delhi continues to battle hazardous air pollution with AQI recorded at 335. Authorities implement Stage II GRAP measures as citizens face severe health risks. Latest updates on air quality crisis.
Mumbai faces alarming pollution surge as AQI hits 'Poor' category. Discover the causes behind the toxic haze and expert insights on health risks and solutions.
Delhi-NCR's air quality remains in the 'severe' category as thick smog blankets the region. Punjabi Bagh records worst AQI at 433, with Gurugram and Noida equally affected. Health alerts issued as pollution levels reach hazardous levels.